---
title: "Jefferies Keeps Their Hold Rating on Bayer (0P6S)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295415984.md"
description: "Jefferies analyst Michael Leuchten maintained a Hold rating on Bayer today and set a price target of €46.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks According to TipRanks, Leuchten is ranked #11581 out of 12407 analysts. Bayer has an analyst consensus of Strong Buy, with a price target consensus of €56.64."
datetime: "2026-08-10T13:35:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295415984.md)
  - [en](https://longbridge.com/en/news/295415984.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295415984.md)
generator: "portal-rs"
---

# Jefferies Keeps Their Hold Rating on Bayer (0P6S)

Jefferies analyst Michael Leuchten maintained a Hold rating on Bayer today and set a price target of €46.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Leuchten is ranked #11581 out of 12407 analysts.

Bayer has an analyst consensus of Strong Buy, with a price target consensus of €56.64.

### Related Stocks

- [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md)
- [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)

## Related News & Research

- [Short Interest in Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Increases By 94.9%](https://longbridge.com/en/news/296026963.md)
- [Bayer says Japan approves sevabertinib for HER2-mutant NSCLC](https://longbridge.com/en/news/296745277.md)
- [MustGrow Receives First Milestone Payment from Bayer AG | MGROF Stock News](https://longbridge.com/en/news/296609006.md)
- [BAYN: Strong 2025 results, innovation focus, and €2bn cost savings drive improved financial outlook](https://longbridge.com/en/news/294831947.md)
- [Bayer Swings to Net Profit on Smaller Litigation Charges](https://longbridge.com/en/news/294778020.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**